XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information by Segment The following tables set forth our operating results by segment for the three and six months ended June 30, 2023 and 2022:
RevenueAdjusted EBITDA
Three Months Ended June 30,Three Months Ended June 30,
(in thousands)2023202220232022
Healthcare Solutions$60,874 $71,746 $11,394 $16,149 
Industrial Solutions67,32068,2992,264 2,728 
Total Reportable segments128,194140,04513,658 18,877 
Corporate and Other(1)
— — (20,556)(21,455)
Total Company$128,194 $140,045 $(6,898)$(2,578)
RevenueAdjusted EBITDA
Six Months Ended June 30,Six Months Ended June 30,
(in thousands)2023202220232022
Healthcare Solutions$109,599 $136,091 $16,459 $31,918 
Industrial Solutions139,831136,9559,166 9,293 
Total Reportable segments249,430273,04625,625 41,211 
Corporate and Other(1)
— — (42,618)(41,862)
Total Company$249,430 $273,046 $(16,993)$(651)

(1) Corporate is not an operating segment, but reflects expenses not directly attributable to and, accordingly, not allocated to our reportable segments. These expenses relate to corporate functions such as human resources, finance, and legal and include expenses such as salaries, benefits, and other related costs. Similar to the Company's operating segments, Corporate results are reported to and reviewed by the Companys CODM on the basis of Adjusted EBITDA.
The following table provides a reconciliation of the Company’s reported net loss to the total of our reportable segment Adjusted EBITDA and Corporate and Other Adjusted EBITDA for the three and six months ended June 30, 2023 and 2022:
Three Months EndedSix Months Ended
(in thousands)June 30, 2023June 30, 2022June 30, 2023June 30, 2022
Net loss attributable to 3D Systems Corporation$(28,895)$(32,961)$(58,316)$(59,760)
Interest (income) expense, net(4,404)(1,825)(8,209)(1,990)
Provision (benefit) for income taxes222 1,289 230 2,573 
Depreciation expense5,294 5,032 10,606 10,850 
Amortization expense3,258 3,303 6,497 5,980 
Stock-based compensation expense7,9907,40318,28220,061
Acquisition and divestiture-related expense1,5122,9724,1886,654
Litigation costs2,65610,7602,73510,773
Restructuring expense4,121(10)5,824 301 
Redeemable non-controlling interest16(37)(92)(37)
Loss on equity method investment142— 142— 
Other non-operating (income) expense1,1901,4961,1203,944
Adjusted EBITDA$(6,898)$(2,578)$(16,993)$(651)